Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Celltrion Eyes Direct Global Sales To Bolster Margins, Growth

Mon, 01/07/2019 - 4:21pm

Biosimilar specialist Celltrion is aiming for the next stage of growth by setting up its own global direct sales and...

      Related Stories 

Mersana Axes Lead ADC Compound, Puts All Its Eggs In NaPi2b Basket

Mon, 01/07/2019 - 1:16pm

Mersana Therapeutics has discontinued its lead candidate because of the competitive landscape surrounding HER2-targeted therapies, and will refocus on its...

      Related Stories 

Deal Watch: Sanofi Retains Options To Two Bispecifics While Exiting Antibody Pact With Regeneron

Mon, 01/07/2019 - 1:10pm

Sanofi and Regeneron terminate the immuno-oncology partnership signed in 2015, but will continue to collaborate on Libtayo. Biogen signs a...

      Related Stories 

Finance Watch: Former Juno Execs Launch Sana With Allogeneic Cell Therapy Platform

Mon, 01/07/2019 - 12:24pm

Private Company Edition: Former Juno execs launch allogeneic cell therapy venture Sana, Atlas raises a $250m fund, and the Rakuten...

      Related Stories 

Lift-Off For Lilly In Cancer Genetics With Loxo Buy

Mon, 01/07/2019 - 7:58am

The New Year is just a week old but the biopharma merger and acquisitions merry-go-round is already spinning furiously as...

      Related Stories 

AstraZeneca Rejig Brings Baselga On Board

Mon, 01/07/2019 - 7:31am

A reorganization at the top of the UK firm brings with it controversial scientist Jose Baselga.

      Related Stories 

Key Trends In CDMO Space As Dissected By Piramal Pharma Solutions CEO

Sun, 01/06/2019 - 2:03pm

Piramal Pharma Solutions CEO Vivek Sharma discusses a range of issues shaping the buzzing contract development and manufacturing segment in...

      Related Stories 

IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year

Fri, 01/04/2019 - 1:36pm

Nearly two-thirds of the 67 drug developers that launched an IPO in 2018 were trading below their offering price at...

      Related Stories 

Pipeline Watch: Phase III Starts With Sparsentan, Reloxaliase And Xenex

Fri, 01/04/2019 - 1:35pm

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

Jallal To Lead Immunocore, Building On Partnership She Forged At MedImmune

Fri, 01/04/2019 - 1:07pm

A key figure in AstraZeneca’s resurgence, Jallal now leaves to head up a clinical-stage firm. She’s been an outspoken advocate...

      Related Stories 

Scrip’s Top Five Stories Of 2018

Fri, 01/04/2019 - 6:44am

A look back at the Scrip stories that piqued the most interest for our readers in 2018. 

      Related Stories 

Tizona Lands AbbVie Cancer R&D Deal As New CEO Takes Control

Fri, 01/04/2019 - 5:41am

California-based Tizona has begun 2019 by installing a new CEO and winning a lucrative early-stage R&D pact with AbbVie aimed...

      Related Stories 

Oculis Eyes Opportunities With Fresh Funding and Novartis Licensing Deal

Fri, 01/04/2019 - 5:31am

As Novartis looks to move out of much of its ophthalmology research with the forthcoming spinoff of Alcon, fellow Swiss...

      Related Stories 

Sanofi Takes €80M BioNTech Stake & Extends 2015 Deal

Fri, 01/04/2019 - 12:06am

  BioNTech gets an €80m boost to its reserves as Sanofi takes equity stake as partners extend 2015 deal and advance...

      Related Stories 

Duet Or Duel: Will 2019 See More India Pharma Linkages In China?

Thu, 01/03/2019 - 10:39pm

2018 has seen some interesting Indo-Chinese pharma linkages amid evolving regulations in China and generally improved overall ties between the...

      Related Stories